The latest data from the phase 1 trial are encouraging,” said the study's lead author.

A new study from Memorial Sloan Kettering Cancer Center shows good results for patients with pancreatic cancer. They used a ...

A new type of mRNA vaccine, added to standard cancer treatment, could help some patients with pancreatic cancer live longer.

Recent positive lab confirmation of Smart mRNA functionality is a tremendous milestone for the Company. This marks a ...

Clinical studies suggest that the mRNA vaccine could aid in treating pancreatic cancer, one of the most lethal forms of ...

Clinical studies suggest that the mRNA vaccine may play a role in treating pancreatic cancer, identified as one of the most ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

Pancreatic cancer remains one of the deadliest forms of cancer, with an alarming 90% mortality rate among diagnosed patients.

Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...